glp-1 drugs stocks Eli Lilly is not just a pharma stock right now. It is one of the market's clearest growth stories. Reuters reported Lilly raised its annual profit and revenue forecasts as 3 GLP-1 Stock Picks: LLY,

US$ 29.12

★★★★★ 5.0 (8 reviews)

US$ 27.48

★★★★★ 4.9 (20 reviews)

US$ 27.47

★★★★★ 4.5 (16 reviews)

US$ 25.22

★★★★★ 5.0 (14 reviews)

US$ 21.70

★★★★★ 4.3 (19 reviews)

US$ 22.34

★★★★★ 5.0 (28 reviews)

US$ 23.36

★★★★★ 4.7 (10 reviews)

US$ 24.82

★★★★★ 4.1 (13 reviews)

US$ 22.98

★★★★★ 4.0 (21 reviews)

US$ 21.91

★★★★★ 4.5 (17 reviews)

US$ 27.05

★★★★★ 4.6 (12 reviews)

US$ 28.42

★★★★★ 4.6 (29 reviews)

US$ 20.53

★★★★★ 5.0 (16 reviews)

US$ 24.99

★★★★★ 4.8 (7 reviews)

US$ 23.06

★★★★★ 4.8 (18 reviews)

US$ 27.26

★★★★★ 4.1 (26 reviews)

US$ 21.15

★★★★★ 4.0 (12 reviews)

US$ 25.58

★★★★★ 4.4 (6 reviews)

US$ 21.55

★★★★★ 4.6 (20 reviews)

US$ 29.24

★★★★★ 4.3 (17 reviews)